The authors declare that they have no competing interests
JP coordinated data collection, conducted the data analysis and drafted the manuscript. MWH, PMS, IM designed the study and critically revised the manuscript. All authors’ read and approved the final manuscript.
This study aimed to document malaria case management practices in Papua New Guinea prior to the introduction of a revised national malaria treatment protocol. The revised protocol stipulates routine testing of malaria infection by rapid diagnostic test or microscopy, anti-malarial prescription to test positive cases only, and the introduction of a new artemisinin-based first-line anti-malarial. Findings presented in this paper primarily focus on diagnostic, prescription and treatment counselling practices.
In a national cross-sectional survey of 79 randomly selected health facilities, data were collected via non-participant observation of the clinical case management of patients presenting with fever or a recent history of fever. Data were recorded on a structured clinical observation instrument.
Overall, 15% of observed fever patients (n = 468) were tested for malaria infection by rapid diagnostic test and a further 3.6% were tested via microscopy. An anti-malarial prescription was made in 96.4% (451/468) of cases, including 100% (17/17) of test positive cases and 82% (41/50) of test negative cases. In all, 79.8% of anti-malarial prescriptions conformed to the treatment protocol current at the time of data collection. The purpose of the prescribed medication was explained to patients in 63.4% of cases, dosage/regimen instructions were provided in 75.7% of cases and the possibility of adverse effects and what they might look like were discussed in only 1.1% of cases.
The revised national malaria treatment protocol will require a substantial change in current clinical practice if it is to be correctly implemented and adhered to. Areas that will require the most change include the shift from presumptive to RDT/microscopy confirmed diagnosis, prescribing (or rather non-prescribing) of anti-malarials to patients who test negative for malaria infection, and the provision of thorough treatment counselling. A comprehensive clinician support programme, possibly inclusive of ‘booster’ training opportunities and regular clinical supervision will be needed to support the change.
World Health Organization: World Malaria Report 2010. 2010, WHO, Geneva CrossRef
Mueller I, Bockarie M, Alpers M, Smith T: The epidemiology of malaria in Papua New Guinea. Trends Parasitol. 2003, 19: 253-259. 10.1016/S1471-4922(03)00091-6. CrossRef
Macfarlane JE: A focused ethnography about treatment-seeking behaviour and traditional medicine in the Nasioi area of Bougainville. P N G Med J. 2008, 51: 29-42. PubMed
Papua New Guinea National Department of Health: Standard Treatment for Common Illnesses of Children in Papua New Guinea: A Manual for Nurses, Community Health Workers, Health Extension Officers and Doctors. 2005, PNG NDoH, Port Moresby
Papua New Guinea National Department of Health: Standard Treatment for Common Illnesses of Adults in Papua New Guinea: A Manual for Nurses, Community Health Workers, Health Extension Officers and Doctors. 2005, PNG NDoH, Port Moresby
Marfurt J, Mueller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B: Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Am J Trop Med Hyg. 2007, 77: 947-954. PubMed
Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM: A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med. 2008, 359: 2545-2557. 10.1056/NEJMoa0804915. CrossRefPubMed
Marfurt J, Smith TA, Hastings IM, Muller I, Sie A, Oa O, Baisor M, Reeder JC, Beck HP, Genton B: Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance. Malar J. 2010, 9: 8-10.1186/1475-2875-9-8. PubMedCentralCrossRefPubMed
World Health Organization: Guidelines for the treatment of malaria. 2006, WHO, Geneva
Papua New Guinea National Department of Health: National malaria treatment protocol. 2009, PNG NDoH, Port Moresby
Hetzel MW, Gideon G, Mueller I, Siba PM: Papua New Guinea/The Global Fund Round 3 Malaria Control Programme Evaluation 2008/2009: Results from Cross Sectional Surveys and Sentinel Sites. 2010, ,
World Health Organization: Review of the malaria drug efficacy situation in 10 countries of the WHO Western Pacific Region 1987–2003. 2005, WHO, Geneva
World Health Organization: Global plan for artemisinin resistance containment (GPARC) Geneva. 2011, WHO, Geneva
Ansah EK, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey AA, Gyapong J, Whitty CJ: Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ. 2010, 340: c930-10.1136/bmj.c930. PubMedCentralCrossRefPubMed
Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, Snow RW: The effect of mobile phone text-message reminders on Kenyan health workers’ adherence to malaria treatment guidelines: a cluster randomised trial. Lancet. 2011, 378: 795-803. 10.1016/S0140-6736(11)60783-6. PubMedCentralCrossRefPubMed
- Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol
Peter M Siba
Manuel W Hetzel
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II